FMR LLC bought AVLN
May 1, 2026 · Form 4 insider transaction
FMR LLC bought 80,291 shares of Avalyn Pharma Inc., a transaction worth N/A. The trade was recorded as conversion of a derivative and disclosed on an SEC Form 4, filed 4 days after the transaction.
Direction
Acquired (buy-side)
Shares
80,291
Price
N/A
Total value
N/A
InsiderFMR LLC
Role10% owner
CompanyAvalyn Pharma Inc. (AVLN)
SecurityCommon Stock
Transaction codeC: Conversion of a derivative
Transaction dateMay 1, 2026
Filing dateMay 5, 2026
Shares owned after807,876
OwnershipIndirect
10b5-1 planNo
AmendedNo
Footnotes
On May 1, 2026, in connection with the completion of the issuer's initial public offering, each share of Series A Preferred Stock, Series B Preferred Stock, Series C-1 Preferred Stock, Series C-2 Preferred Stock, and Series D Preferred Stock converted on a 1-for-1 basis into shares of Common Stock.